Está en la página 1de 6

Topical Review

Cerebrovascular Disease, Amyloid Plaques, and Dementia


Wenyan Liu, MD; Adrian Wong, PhD; Andrew C.K. Law, MD, PhD; Vincent C.T. Mok, MD

A myloid plaques are depositions of amyloid (A) pro-


tein in the cerebral parenchyma and considered as one
of the neuropathological diagnostic hallmarks of Alzheimers
transient ischemic attack and 31.1% of patients with clinical
diagnosis of subcortical vascular dementia (VaD).24,25 These
findings are in keeping with the prevalence reported in neu-
disease (AD).1 Cerebrovascular disease (CVD) is also highly ropathological studies showing that AD pathology, including
prevalent among the elderly and is commonly found in both amyloid plaques and neurofibrillary tangles, was found
patients with AD.2 Autopsy studies conducted during the past between 25.8% and 55.6% of patients diagnosed with possible
2 decades show that amyloid plaques frequently coexist with VaD.4648
CVD, and the 2 may interact to modulate the risks and expres-
sion of clinical dementia.2 Neuropathological examinations Interactions Between CVD and Amyloid
show that between 6% and 47% individuals with dementia Plaques
had coexisting AD and CVD pathologies (Table).320 Indeed, Being the 2 commonest causes for dementia, mounting evi-
mixed pathologies may account for the majority of dementia dence shows that CVD and AD share risk factors, including
cases (38%).11 age, hypertension, diabetes mellitus, hypercholesterolaemia,
Although autopsy study is considered the gold standard ischemic heart disease, and smoking.1 Research findings on
for determining the underlying pathology of dementia, it has the relationship between CVD and amyloid accumulation are
inherent limitations with correlating pathological and clini- discussed below.
cal findings. In particular, uncertainties exist with regard to
the temporal relationship between the development of brain Neurovascular Unit and Amyloid Plaques
lesions and dementia syndrome because of the time lag Amyloid accumulation may occur a decade or more before
between dementia onset and autopsy. Moreover, the exact the emergence of clinical symptoms of cognitive decline.49
severity or extent of certain manifestations of CVD, in par- Alterations in neurovascular unit may take part in the pro-
ticular, white matter changes (WMC), is difficult to quantify cess.50 According to the 2-hit vascular hypothesis of AD,
in autopsy studies.21 Also, heterogeneity in the definition of impaired bloodbrain barrier and reduced cerebral blood
CVD lesions (eg, lacunar infarct) might contribute to incon- flow, caused by neurovascular unit dysfunction, may
sistency in assessments between neuropathologists.21 induce A accumulation in addition to direct damage to
Clinical in-vivo study investigating the relationship neurons.50,51 Apolipoprotein E-4, which is associated with
between amyloid plaques and cognitive impairment has only both cerebrovascular lesions and late-onset sporadic AD,
been made possible a decade ago with the advent of amyloid may also contribute to amyloid formation via vascular
imaging, such as Carbon-11-labeled Pittsburgh Compound B mechanisms.52 Different from the direct neurotoxic effects
(PiB) positron emission tomography (PET). Other amyloid of parenchymal amyloid plaques, amyloid deposits in
ligands, such as flutemetamol (GE-067), florbetaben (BAY- vessels are associated with cerebral amyloid angiopathy
949172, AV-1), and florbetapir (AV-45) have also become (CAA). Vascular amyloid may disrupt bloodbrain barrier
available to the market in recent years.22 Amyloid PET can function and rupture the vessels, causing the leakage of the
detect comorbid amyloid deposition in patients with high vas- serum proteins and red blood cells into brain parenchyma.
cular burden.23 We reviewed the potential interactions between Together, these series of events set the stage for the for-
CVD and amyloid plaques and their relationships with cog- mation of amyloid plaques.50 This hypothesis is supported
nitive impairment, with reference to in-vivo clinical studies by pathological observations of an preferential accumula-
using amyloid PET imaging2440 and autopsy studies measur- tion of amyloid plaques around capillaries with CAA in
ing amyloid plaques.4145 patients with AD.53 In young APP23 transgenic mouse
(a mouse model for AD), vessels deformation and attach-
Prevalence of Amyloid Plaques in Subjects ment by small amyloid deposits were found before the
With CVD presence of amyloid plaques in the parenchyma, suggesting
Using amyloid PET, AD-like PiB retention was found in that microvasculature alternations may be an early event in
29.7% of patients with incident dementia after stroke or the formation of amyloid plaques.54

Received October 15, 2014; accepted February 23, 2015.


From the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China (W.L., A.W., V.C.T.M.); and Neural
Dysfunction Research Laboratory, Department of Psychiatry, The University of Hong Kong, Hong Kong, China (A.C.K.L.).
Correspondence to Adrian Wong, PhD, Department of Medicine and Therapeutics, 10/F Clinical Sciences Bldg, Prince of Wales Hospital, The Chinese
University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China. E-mail adrianwong@cuhk.edu.hk
(Stroke. 2015;46:1402-1407. DOI: 10.1161/STROKEAHA.114.006571.)
2015 American Heart Association, Inc.
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.114.006571

1402
Liu et al Cerebrovascular Disease, Amyloid, and Cognition 1403

Table. Pathology Findings in Dementia


Author Setting No. Mean Age, y AD+CVD (%) Pure AD (%) Pure VaD (%) LBD (%) FTD (%) Others (%)
Victoroff3 Hospital 196 d 76.6 25 (12.8%) 88 (44.9%) 9 (4.6%) 13 (6.6%) NA 61 (31.1%)
Snowdon 4
Convents 45 d 76100 21 (47%) NA NA NA NA NA
Nolan5 Hospital 87 d NA 32 (37%) 44 (50.6%) NA NA 11 (12.6%)
Seno6 Nursing home 122 d 83.68.3 14 (11%) 41 (34%) 42 (35%) NA NA 25 (20%)
Barker7 Hospital 382 d 7913 43 (11%) 159 (42%) 12 (3%) 99 (25.9%)* 21 (5.5%) 48 (12.6%)
Akatsu 8
Geriatric 158 d 81.28.3 9 (6%) 73 (46%) 34 (22%) 28 (18%) 14 (8%)
hospital
Riekse9 Community 124 d 65+ 18 (14.5%) 30 (24.2%) 8 (6.5%) NA NA 124 (54.8%)
Petrovitch10 Community 333 (120 d) 78 22 (18.3%) 37 (30.8%) 35 (29.2%) 26 (21.7%)
(HAAS)
Schneider11 Community 141 (50 d) 87.85.6 19 (38%) 15 (30%) 6 (12%) NA 10 (20%)
(the Rush MAP)
Brunnstrm12 Hospital 524 d 80 (39102) 113 (21.6%) 220 (42%) 124 (23.7%) 1 (0.2%) 21 (4%) 45 (8.6%)
Schneider 13
Community 179 d 86.9 54 (30.2%) 76 (42.4%) 8 (4.5%) 30 (16.8%)* NA 11 (6.2%)
(the Rush ROS
and MAP)
Brayne14 Community 213 (113 d) 91.1 (81101) 25 (22.1%) 76 (67.2) 4 (3.5%) 1 (1%) NA 7 (6%)
(CC75C study)
White15 Community 443 (183 d) 7290+ 26 (14.2%) 34 (18.6%) 62 (33.8%) 20 (10.9%) 41 (22.4%)
(HAAS)
Jellinger16 Hospital 1700 d 84.35.4 473 (27.8%) 775 (45.6%) 209 (12.3%) 158 (9.3%) NA 85 (5%)
Sinka17 Hospital 93 (86 d) 90103 17 (19.7%) 48 (55.8%) 21 (24.4%)
Echavarri 18
Hospital 200 d 78.7 (15100) 31 (16%) 52 (26%) 4 (2%) 1 (0.5%) 4 (2%) 113 (56.5%)
Grinberg19 Community 1291 (113 d) 78.39.7 15 (13.3%) 40 (35.4%) 24 (21.2%) NA NA 34 (30.1%)
(BBBABSG)
Magaki20 Hospital 218 d 50100 24 (11%) 123 (56.4%) 1 (0.5%) 31 (14.2%)* 14 (6.4%) 25 (11.5%)
AD indicates Alzheimers disease; BBBABSG, Brain Bank of the Brazilian Aging Brain Study Group; CC75C, Cambridge City Over-75s Cohort; CVD, cerebrovascular
disease; d, number of patients with dementia; FTD, frontotemporal dementia; HAAS, Honolulu-Asia Aging Study; LBs, Lewy bodies; LBD, Lewy body disease; MAP, Rush
Memory and Aging Project; NA, not available; ROS, Religious Order Study; and VaD, vascular dementia.
*Including LBs+others.
Including FTD+others.
AD+others, but most are AD+CVD.

However, an unresolved issue remains on the temporal rela- Infarcts and Amyloid Plaques
tionship between the development of vascular and amyloid Most amyloid PET studies did not find significant relation-
pathologies as other potential factors, such as the overproduction ships between infarcts and amyloid deposition.27,28 In fact,
of A caused by genetic mutations in APP and presenilin genes a study showed that in patients with subcortical vascular
might also take part in the abnormal amyloid accumulation.1 cognitive impairment, the number of lacunes was negatively
related with the PiB retention ratio.29 In patients with recent
Atherosclerosis and Amyloid Plaques ischemic stroke, although a relatively increased PiB reten-
Atherosclerosis in large cerebral arteries can compromise tion was found in peri-infarct region comparing to the con-
cerebral blood flow and cause cerebral hypoperfusion. Patients tralateral mirror region, this increased regional PiB retention
with AD had a higher proportion and more pronounced athero- did not translate into a higher global PiB retention.30 In
sclerosis in the circle of Willis than those patients with non- experimental stroke models in transgenic mouse with amy-
AD dementias (except VaD) as shown in autopsy studies.41,5558 loid deposition (APPswe/PS1dE9), increase in new amy-
Moreover, there was a high concordance between the ratings loid plaques around the infarcted area was only transient, in
of atherosclerosis with amyloid plaques and CAA ratings.41 which the accumulation most probably reflected an impaired
Through [18F] AV-45 PET examination, amyloid deposition amyloid clearance pathway caused by infarcted tissue.59
in patients with dementia having unilateral carotid artery ste- Moreover, the possibility that the observed increase in local
nosis was increased. More importantly, the distribution of the PiB retention being a result of leakage of free PiB because
amyloid disposition was found to be lateralized to the side of of the bloodbrain barrier damage could not be excluded.30
stenosis.26 Together, these clinical and pathological findings Overall, thus far, there is no solid evidence of a significant
suggest that there is a shared cause between atherosclerosis interaction between cerebral infarcts and global amyloid
and amyloid deposition. burden.
1404StrokeMay 2015

WMC and Amyloid Plaques expression of dementia. It suggested that concurrent cere-
Pathogenesis of WMC could be multifactorial. Here, we bral infarcts might significantly amplify the risk and severity
specify WMC as age-related WMC, which is suggested to of dementia in patients with neuropathologically confirmed
represent incomplete infarct related to small vessel disease. AD.4 More recent studies using amyloid PET also showed
WMC is generally hypothesized to be associated with demy- converging findings. For example, PiB-positive (PiB+) sub-
elination, loss of oligodendrocytes, and axonal damage.60 cortical patients with VaD had lower cognitive performance
Findings about the relationship between WMC and amyloid than those who were PiB-negative (PiB).25 Interestingly,
accumulation seem to be inconsistent. In general, most stud- there seems to be a dynamic balance between amyloid depo-
ies showed a lack of correlation between WMC and amy- sition and CVD pathologies on the expression of demen-
loid load.2729,31,32 However, there were also studies showing tia because on a given level of cognitive impairment, less
positive relationships between WMC and amyloid.33,34 For amount of one kind of pathology is found when the amount
instance, in sporadic AD patients, WMC at baseline was sig- of other kind of pathology increases. For example, in neuro-
nificantly related to the progression of amyloid deposition in pathological studies, amyloid plaques were found to be fewer
28 months,33 suggesting that WMC might accelerate the aggre- in those with CVD lesions.4345 Among patients with post-
gation of amyloid protein produced in situ. However, the posi- stroke dementia, PiB+ patients had fewer old infarcts than
tive association between WMC and amyloid burden seemed their PiB counterparts.24,25
to be predominant in the posterior brain regions, which are Although findings from above studies raised the possibility
not the typical topography of AD but CAA.34 Another study of a synergistic effect between the 2 pathologies, other study
also reported that the volume of WMC was independently suggested that CVD largely contributed an additive, rather
related to amyloid retention in patients with CAA but not in than synergistic, effect on the expression of dementia against
patients with AD.35 On the basis of these findings, it can be the background of amyloid burden.29 Note that synergistic
speculated that WMC may be more closely linked to vascular effects between the 2 pathologies might be specific to cogni-
amyloid deposition associated with CAA rather than paren- tive domains such as visuospatial functions.39
chymal amyloid deposition characteristic of AD. Noteworthy
is that a study among cognitively normal individuals showed Contributions of Comorbid CVD and Amyloid
that gray matter regions with more WMC had lower amyloid Plaques on Expression of Dementia
deposition.36 It was hypothesized that WMC might disrupt the The amyloid hypothesis posits that the amyloid deposition
entry of misfolded proteins from white matter tracts and thus on its own is an early step in the development of cognitive
resulted in lower amyloid load in gray matter regions.36 In impairment.49 The accumulation of amyloid in the aging brain
view of these conflicting results, further investigation between causes oxidative and inflammatory effects, which lead to neu-
WMC and amyloid is warranted. ronal death and synaptic failure, and eventually result in brain
atrophy and cognitive impairment. Although the detrimental
Microbleeds and Amyloid Plaques effects of A on neuron and synapse have been observed in
The number of studies on the association of microbleeds and animal models, it remains unclear how much A deposition
amyloid burden are limited.37,38,42 Two studies revealed posi- is required to instigate the neurodegenerative process and
tive findings.37,42 In a postmortem study using immunohisto- finally results in cognitive dysfunction. Given that amyloid
chemical staining, the majority of A deposits were found to burden could be found in 20% to 30% cognitively normal
be at or near the capillary hemorrhage sites.42 The Australian older adults,62,63 the threshold of amyloid plaques for cognitive
Imaging, Biomarkers, and Lifestyle Study of Aging Research manifestation is likely to be modulated by individual differ-
group showed that the prevalence and incidence of micro- ences, such as brain and cognitive reserve, and other environ-
bleeds were both significantly higher in AD than in cogni- mental factors.49
tively normal individuals.37 However, converging evidence Concurrent CVD lesions may catalyze or trigger the onset
showed that microbleeds in AD were more linked to CAA and of clinical dementia in asymptomatic or subclinical individu-
related increased bloodbrain barrier permeability, rather than als with amyloid plaques by several ways. First, CVD may
amyloid disposition.38 Autopsy study showed that microbleeds impair cognition directly via neuronal death and synaptic
in AD with CAA were found in all brain sections, whereas failure independent of amyloid.2 According to laboratory
in AD without CAA, microbleeds were only predominate in research, the neurovascular dysfunction could cause oxida-
the central coronal sections.61 This observed discrepancy on tive stress and inflammation via nonamyloidogenic pathway,
topographical distribution of microbleeds may differentiate leading to neuronal loss.2,50 Second, according to the afore-
AD patients with and without CAA. mentioned 2-hit vascular hypothesis, the neurovascular dys-
function is also associated with an increased accumulation of
amyloid plaques.50 Third, decreased number of viable neu-
Interactions Between CVD, Amyloid Plaques
rons caused by the CVD lesions may reduce brain reserve
on Cognition
and subsequently the resilience of the brain against the
Comorbid CVD and Amyloid Plaques on detrimental effects from amyloid-mediated neurotoxicity.
Expression of Dementia Therefore, concurrent CVD lesions may lower the thresh-
The Nun study was a landmark study that revealed a con- old for clinical manifestation of cognitive impairment with
certed effect of lacunes and AD pathologies on clinical amyloid burden.
Liu et al Cerebrovascular Disease, Amyloid, and Cognition 1405

In addition to possible pathological mechanisms mentioned Conclusions and Future Directions


above, in clinical setting, the presence of concurrent CVD Autopsy and amyloid PET studies showed the existence of
may increase the likelihood for patients to receive a diagno- comorbid CVD and amyloid deposition in patients with cog-
sis of dementia. In the early stage of amyloid deposition, a nitive impairment. Underlying microvasculature alternation
diagnosis of dementia is more likely to be established in the may contribute to an early accumulation of amyloid. With
presence of deficits on multiple cognitive domains contributed aging, emergence of CVD could further affect cognition in
concurrently by frontal dysfunction associated with cerebro- those patients with preexisting amyloid by causing direct
vascular lesions.64 When the invasion of amyloid progresses neuronal damage and accelerating the amyloid deposition.
to later stage and involves in all areas of the isocortex, the Concurrent CVD may also lower the brain reserve against
superimposed cognitive dysfunction caused by CVD will be cognitive effects from amyloid disposition, and vice versa.
difficult to distinguish.65 This may be one of the reasons why Nevertheless, relationships between amyloid deposition
CVD lesions play a greater role in the development of demen- and different kinds of cerebrovascular lesions are still unclear.
tia in people with fewer amyloid plaques than those with more Longitudinal studies with repeated amyloid and MRI in
severe deposition. young subjects with high risks of CVD or AD will be help-
ful to study the evolution in the development and interactions
Comorbid CVD and Amyloid Plaques on Cognitive between CVD and amyloid deposition. In addition, the valid-
Profile of Dementia ity of neuropsychological paradigms such as intraindividual
In AD, amyloid has most robust effects on episodic memory variability measures may be examined in conjunction with the
among the cognitive domains.66 In contrast, executive dys- use of computerized testing technology as a way to differenti-
function tends to be typically more prominent in patients ate underlying pathology and predict clinical course. In clini-
with subcortical vascular disease, such as individuals exhibit- cal practice, aggressive control of risk factors of CVD will
ing lacunes and WMC, in which their effects are more pro- probably prevent or delay onset of dementia in elderly sub-
nounced on the frontosubcortical system.67 Such dissociations
jects harboring amyloid plaques. Furthermore, active lifestyle
have been demonstrated in patients with mixed pathologies.
engagement, such as physical activities and mental stimula-
For example, in patients with subcortical VaD and mild cogni-
tion has been found to be associated with reduced CVD risks
tive impairment, amyloid burden seemed to be more related
and amyloid burden.71,72 Clinical trials are needed to study the
to episodic memory decline, whereas WMC was associated
modulating effects of lifestyle intervention on clinical and
with poor executive function.25,29,39 A path analysis study
neuroimaging markers of CVD and AD for primary preven-
showed that memory deficits related to amyloid burden was
tion of dementia in our rapidly aging populations.
mediated by hippocampal atrophy, whereas WMC affected
executive function via frontal thinning.40 However, the rela-
tionships between cognitive domains and pathologies may Sources of Funding
not be straightforward. For example, WMC could also affect This work was supported by Health and Health Services Research
Fund 07080411 and Lui Che Woo Institute of Innovative Medicine.
episodic memory by affecting working memory and executive
retrieval with frontal dysfunction.40 In addition, amyloid and
CVD might influence memory and executive function inde- Disclosures
pendent of brain atrophy.40 None.
Several possibilities may explain the overlaps of the cogni-
tive domains associated with amyloid deposition and CVD. References
First, cerebral regions affected by amyloid deposition and 1. Blennow K, de Leon MJ, Zetterberg H. Alzheimers disease. Lancet.
CVD may overlap. Distribution of amyloid deposition is typi- 2006;368:387403. doi: 10.1016/S0140-6736(06)69113-7.
2. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola
cally observed in the frontal cortex, posterior cingulate, pre- C, et al; American Heart Association Stroke Council, Council on
cuneus, caudate, parietal cortex, and lateral temporal cortex, Epidemiology and Prevention, Council on Cardiovascular Nursing,
which are brain regions involved in a wide range of cogni- Council on Cardiovascular Radiology and Intervention, and Council on
tive processes, including executive functions, attention, and Cardiovascular Surgery and Anesthesia. Vascular contributions to cog-
nitive impairment and dementia: a statement for healthcare profession-
memory. Locations of cerebrovascular lesions in individuals als from the American Heart Association/American Stroke Association.
are variable in CVD. In addition to executive dysfunction, Stroke. 2011;42:26722713. doi: 10.1161/STR.0b013e3182299496.
cerebrovascular lesions in posterior cerebral artery territory 3. Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopatho-
may also affect the medial temporal lobe with consequential logical correlation in dementia. Am J Psychiatry. 1995;152:14761484.
4. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA,
memory failure.68 Second, distinct cerebral regions are asso- Markesbery WR. Brain infarction and the clinical expression of
ciated with multiple cognitive processes rather than a single Alzheimer disease. The Nun Study. JAMA. 1997;277:813817.
cognitive function. For instance, both executive functions and 5. Nolan KA, Lino MM, Seligmann AW, Blass JP. Absence of vascular
dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc.
memory are subserved by the frontal lobes and related path-
1998;46:597604.
ways.69 Third, in addition to brain atrophy, functional network 6. Seno H, Ishino H, Inagaki T, Iijima M, Kaku K, Inata T. A neuropatho-
disruptions may also impair cognition.70 Therefore, given that logical study of dementia in nursing homes over a 17-year period, in
differences in neuropsychological profiles between AD, VaD, Shimane Prefecture, Japan. Gerontology. 1999;45:4448.
7. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein
and mixed dementia are less distinct than expected, it may be
D, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular
clinically difficult to distinguish pathologies based on cogni- and frontotemporal dementia, and hippocampal sclerosis in the State of
tive profile alone. Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16:203212.
1406StrokeMay 2015

8. Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, 29. Park JH, Seo SW, Kim C, Kim SH, Kim GH, Kim ST, et al. Effects of
et al. Subtype analysis of neuropathologically diagnosed patients in a cerebrovascular disease and amyloid beta burden on cognition in sub-
Japanese geriatric hospital. J Neurol Sci. 2002;196:6369. jects with subcortical vascular cognitive impairment. Neurobiol Aging.
9. Riekse RG, Leverenz JB, McCormick W, Bowen JD, Teri L, Nochlin 2014;35:254260. doi: 10.1016/j.neurobiolaging.2013.06.026.
D, et al. Effect of vascular lesions on cognition in Alzheimers disease: 30. Ly JV, Rowe CC, Villemagne VL, Zavala JA, Ma H, Sahathevan R, et al.
a community-based study. J Am Geriatr Soc. 2004;52:14421448. doi: Subacute ischemic stroke is associated with focal 11C PiB positron emis-
10.1111/j.1532-5415.2004.52405.x. sion tomography retention but not with global neocortical A deposition.
10. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Stroke. 2012;43:13411346. doi: 10.1161/STROKEAHA.111.636266.
Davis D, et al. AD lesions and infarcts in demented and non-demented 31. Hedden T, Mormino EC, Amariglio RE, Younger AP, Schultz AP, Becker
Japanese-American men. Ann Neurol. 2005;57:98103. doi: 10.1002/ JA, et al. Cognitive profile of amyloid burden and white matter hyperin-
ana.20318. tensities in cognitively normal older adults. J Neurosci. 2012;32:16233
11. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain 16242. doi: 10.1523/JNEUROSCI.2462-12.2012.
pathologies account for most dementia cases in community-dwell- 32. Hedden T, Van Dijk KR, Shire EH, Sperling RA, Johnson KA, Buckner
ing older persons. Neurology. 2007;69:21972204. doi: 10.1212/01. RL. Failure to modulate attentional control in advanced aging linked
wnl.0000271090.28148.24. to white matter pathology. Cereb Cortex. 2012;22:10381051. doi:
12. Brunnstrm H, Gustafson L, Passant U, Englund E. Prevalence of demen- 10.1093/cercor/bhr172.
tia subtypes: a 30-year retrospective survey of neuropathological reports. 33. Grimmer T, Faust M, Auer F, Alexopoulos P, Frstl H, Henriksen G,
Arch Gerontol Geriatr. 2009;49:146149. doi: 10.1016/j.archger.2008.06.005. et al. White matter hyperintensities predict amyloid increase in
13. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropa- Alzheimers disease. Neurobiol Aging. 2012;33:27662773. doi:
thology of probable Alzheimer disease and mild cognitive impairment. 10.1016/j.neurobiolaging.2012.01.016.
Ann Neurol. 2009;66:200208. doi: 10.1002/ana.21706. 34. Noh Y, Seo SW, Jeon S, Lee JM, Kim JH, Kim GH, et al. White mat-
14. Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, ter hyperintensities are associated with amyloid burden in APOE4 non-
et al; Cambridge City Over-75s Cohort Cc75c Study Neuropathology carriers. J Alzheimers Dis. 2014;40:877886. doi: 10.3233/JAD-130461.
Collaboration. Neuropathological correlates of dementia in over-80- 35. Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S,
year-old brain donors from the population-based Cambridge city over- Dumas A, et al. Cerebral amyloid angiopathy burden associated with leu-
75s cohort (CC75C) study. J Alzheimers Dis. 2009;18:645658. doi: koaraiosis: a positron emission tomography/magnetic resonance imaging
10.3233/JAD-2009-1182. study. Ann Neurol. 2013;73:529536. doi: 10.1002/ana.23830.
15. White L. Brain lesions at autopsy in older Japanese-American men as 36. Glodzik L, Kuceyeski A, Rusinek H, Tsui W, Mosconi L, Li Y, et al.
related to cognitive impairment and dementia in the final years of life: a Reduced glucose uptake and A in brain regions with hyperintensities in
summary report from the Honolulu-Asia aging study. J Alzheimers Dis. connected white matter. Neuroimage. 2014;100:684691. doi: 10.1016/j.
2009;18:713725. doi: 10.3233/JAD-2009-1178. neuroimage.2014.06.060.
16. Jellinger KA, Attems J. Prevalence and pathology of vascular dementia 37. Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O,
in the oldest-old. J Alzheimers Dis. 2010;21:12831293. et al; AIBL Research Group. Incidence of cerebral microbleeds in
17. Sinka L, Kvari E, Gold G, Hof PR, Herrmann FR, Bouras C, et al. preclinical Alzheimer disease. Neurology. 2014;82:12661273. doi:
Small vascular and Alzheimer disease-related pathologic determinants 10.1212/WNL.0000000000000285.
of dementia in the oldest-old. J Neuropathol Exp Neurol. 2010;69:1247 38. van Berckel B, Goos J, Assema DME, Kloet R, Yaqub M, Bakker E, et al.
1255. doi: 10.1097/NEN.0b013e3181ffc3b9. Cerebral amyloid angiopathy in Alzheimers disease is associated with
18. Echvarri C, Burgmans S, Caballero MC, Garca-Bragado F, Verhey FR, increased blood-brain barrier permeability: a quantitative [11C]PiB-PET
Uylings HB. Co-occurrence of different pathologies in dementia: impli- study. Alzheimers Dement. 2013;9:P12P13.
cations for dementia diagnosis. J Alzheimers Dis. 2012;30:909917. doi: 39. Lee MJ, Seo SW, Na DL, Kim C, Park JH, Kim GH, et al. Synergistic
10.3233/JAD-2012-111400. effects of ischemia and -amyloid burden on cognitive decline in patients
19. Grinberg LT, Nitrini R, Suemoto CK, Lucena Ferretti-Rebustini with subcortical vascular mild cognitive impairment. JAMA Psychiatry.
RE, Leite RE, Farfel JM, et al. Prevalence of dementia subtypes in a 2014;71:412422. doi: 10.1001/jamapsychiatry.2013.4506.
developing country: a clinicopathological study. Clinics (Sao Paulo). 40. Ye BS, Seo SW, Kim GH, Noh Y, Cho H, Yoon CW, et al. Amyloid burden,
2013;68:11401145. doi: 10.6061/clinics/2013(08)13. cerebrovascular disease, brain atrophy, and cognition in cognitively impaired
20. Magaki S, Yong WH, Khanlou N, Tung S, Vinters HV. Comorbidity patients [published online ahead of print July 19, 2014]. Alzheimers Dement.
in dementia: update of an ongoing autopsy study. J Am Geriatr Soc. http://dx.doi.org/10.1016/j.jalz.2014.04.521. Accessed July 19, 2014.
2014;62:17221728. doi: 10.1111/jgs.12977. 41. Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB,
21. Pantoni L, Sarti C, Alafuzoff I, Jellinger K, Munoz DG, Ogata J, et al. et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathol-
Postmortem examination of vascular lesions in cognitive impairment: a ogy in neurodegenerative dementias. Brain. 2012;135:37493756. doi:
survey among neuropathological services. Stroke. 2006;37:10051009. 10.1093/brain/aws271.
doi: 10.1161/01.STR.0000206445.97511.ae. 42. Cullen KM, Kcsi Z, Stone J. Microvascular pathology in the aging
22. Herholz K, Ebmeier K. Clinical amyloid imaging in Alzheimers disease. human brain: evidence that senile plaques are sites of microhaemor-
Lancet Neurol. 2011;10:667670. doi: 10.1016/S1474-4422(11)70123-5. rhages. Neurobiol Aging. 2006;27:17861796.
23. Mok V, Leung EY, Chu W, Chen S, Wong A, Xiong Y, et al. Pittsburgh 43. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, et al.
compound B binding in poststroke dementia. J Neurol Sci. 2010;290:135 The effects of additional pathology on the cognitive deficit in Alzheimer
137. doi: 10.1016/j.jns.2009.12.014. disease. J Neuropathol Exp Neurol. 1997;56:165170.
24. Yang J, Wong A, Wang Z, Liu W, Au L, Xiong Y, et al. Risk factors for 44. Etiene D, Kraft J, Ganju N, Gomez-Isla T, Gemelli B, Hyman BT,
incident dementia after stroke and transient ischemic attack. Alzheimers et al. Cerebrovascular pathology contributes to the heterogeneity of
Dement. 2015;11:1623. doi: 10.1016/j.jalz.2014.01.003. Alzheimers disease. J Alzheimers Dis. 1998;1:119134.
25. Lee JH, Kim SH, Kim GH, Seo SW, Park HK, Oh SJ, et al. Identification 45. Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F,
of pure subcortical vascular dementia using 11C-Pittsburgh compound et al. Degenerative and vascular lesions of the brain have synergistic
B. Neurology. 2011;77:1825. doi: 10.1212/WNL.0b013e318221acee. effects in dementia of the elderly. Acta Neuropathol. 2002;103:481487.
26. Huang KL, Lin KJ, Ho MY, Chang YJ, Chang CH, Wey SP, et al. doi: 10.1007/s00401-001-0493-5.
Amyloid deposition after cerebral hypoperfusion: evidenced on [(18)F] 46. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the
AV-45 positron emission tomography. J Neurol Sci. 2012;319:124129. clinical diagnosis of vascular dementia: a prospective clinical and
doi: 10.1016/j.jns.2012.04.014. post-mortem neuropathological study. J Neurol Neurosurg Psychiatry.
27. Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, 1988;51:10371044.
Chui HC, et al. Cerebrovascular disease, -amyloid, and cognition in 47. Gold G, Giannakopoulos P, Montes-Paixao Jnior C, Herrmann FR,
aging. Neurobiol Aging. 2012;33:1006.e251006.e36. doi: 10.1016/j. Mulligan R, Michel JP, et al. Sensitivity and specificity of newly pro-
neurobiolaging.2011.10.001. posed clinical criteria for possible vascular dementia. Neurology.
28. Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, 1997;49:690694.
et al. The aging brain and cognition: contribution of vascular injury and 48. Gold G, Bouras C, Canuto A, Bergallo MF, Herrmann FR, Hof PR, et al.
A to mild cognitive dysfunction. JAMA Neurol. 2013;70:488495. doi: Clinicopathological validation study of four sets of clinical criteria for
10.1001/2013.jamaneurol.405. vascular dementia. Am J Psychiatry. 2002;159:8287.
Liu et al Cerebrovascular Disease, Amyloid, and Cognition 1407

49. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, 61. De Reuck JL, Cordonnier C, Deramecourt V, Auger F, Durieux N, Bordet
et al. Toward defining the preclinical stages of Alzheimers disease: R, et al. Microbleeds in postmortem brains of patients with Alzheimer
recommendations from the National Institute on Aging-Alzheimers disease: a T2*-weighted gradient-echo 7.0 T magnetic resonance imag-
Association workgroups on diagnostic guidelines for Alzheimers ing study. Alzheimer Dis Assoc Disord. 2013;27:162167. doi: 10.1097/
disease. Alzheimers Dement. 2011;7:280292. doi: 10.1016/j. WAD.0b013e318256ecd8.
jalz.2011.03.003. 62. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik
50. Zlokovic BV. Neurovascular pathways to neurodegeneration in RJ, et al. Neuropathology of cognitively normal elderly. J Neuropathol
Alzheimers disease and other disorders. Nat Rev Neurosci. 2011;12:723 Exp Neurol. 2003;62:10871095.
738. doi: 10.1038/nrn3114. 63. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, et al.
51. Jo WK, Law AC, Chung SK. The neglected co-star in the dementia Amyloid imaging results from the Australian Imaging, Biomarkers and
drama: the putative roles of astrocytes in the pathogeneses of major neu- Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31:12751283.
rocognitive disorders. Mol Psychiatry. 2014;19:159167. doi: 10.1038/ doi: 10.1016/j.neurobiolaging.2010.04.007.
mp.2013.171. 64. Romn GC, Royall DR. A diagnostic dilemma: is Alzheimers demen-
52. Zlokovic BV. Cerebrovascular effects of apolipoprotein E: implications tia Alzheimers disease, vascular dementia, or both? Lancet Neurol.
for Alzheimer disease. JAMA Neurol. 2013;70:440444. doi: 10.1001/ 2004;3:141. doi: 10.1016/S1474-4422(04)00674-X.
jamaneurol.2013.2152. 65. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular
53. Miyakawa T, Uehara Y. Observations of amyloid angiopathy and disease and threshold for dementia in the early stages of Alzheimers dis-
senile plaques by the scanning electron microscope. Acta Neuropathol. ease. Lancet. 1999;354:919920. doi: 10.1016/S0140-6736(99)02355-7.
1979;48:153156. 66. Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C,
54. Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T. Altered mor- et al. Profiles of neuropsychological impairment in autopsy-defined
phology and 3D architecture of brain vasculature in a mouse model for Alzheimers disease and cerebrovascular disease. Brain. 2007;130(pt
Alzheimers disease. Proc Natl Acad Sci U S A. 2008;105:35873592. 3):731739. doi: 10.1093/brain/awl385.
doi: 10.1073/pnas.0709788105. 67. Romn GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical
55. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG. Atherosclerosis ischaemic vascular dementia. Lancet Neurol. 2002;1:426436.
of cerebral arteries in Alzheimer disease. Stroke. 2004;35:26232627. 68. Desmond DW. The neuropsychology of vascular cognitive impairment:
doi: 10.1161/01.STR.0000143317.70478.b3. is there a specific cognitive deficit? J Neurol Sci. 2004;226:37. doi:
56. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, 10.1016/j.jns.2004.09.002.
et al. Circle of Willis atherosclerosis: association with Alzheimers dis- 69. Wheeler MA, Stuss DT, Tulving E. Frontal lobe damage produces epi-
ease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol. sodic memory impairment. J Int Neuropsychol Soc. 1995;1:525536.
2007;113:1321. doi: 10.1007/s00401-006-0136-y. 70. Papma JM, de Groot M, de Koning I, Mattace-Raso FU, van der Lugt
57. Roher AE, Tyas SL, Maarouf CL, Daugs ID, Kokjohn TA, Emmerling A, Vernooij MW, et al. Cerebral small vessel disease affects white mat-
MR, et al. Intracranial atherosclerosis as a contributing factor to ter microstructure in mild cognitive impairment. Hum Brain Mapp.
Alzheimers disease dementia. Alzheimers Dement. 2011;7:436444. 2014;35:28362851. doi: 10.1002/hbm.22370.
doi: 10.1016/j.jalz.2010.08.228. 71. Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, ONeil
58. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, JP, et al. Association of lifetime cognitive engagement and low
et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and -amyloid deposition. Arch Neurol. 2012;69:623629. doi: 10.1001/
Alzheimers disease in the Rotterdam Study. Lancet. 1997;349:151154. archneurol.2011.2748.
doi: 10.1016/S0140-6736(96)09328-2. 72. Huerta JM, Chirlaque MD, Tormo MJ, Gavrila D, Arriola L, Moreno-
59. Garcia-Alloza M, Gregory J, Kuchibhotla KV, Fine S, Wei Y, Ayata C, Iribas C, et al. Physical activity and risk of cerebrovascular disease in the
et al. Cerebrovascular lesions induce transient -amyloid deposition. European Prospective Investigation into Cancer and Nutrition-Spain study.
Brain. 2011;134:36973707. doi: 10.1093/brain/awr300. Stroke. 2013;44:111118. doi: 10.1161/STROKEAHA.112.670612.
60. Pantoni L. Cerebral small vessel disease: from pathogenesis and clini-
cal characteristics to therapeutic challenges. Lancet Neurol. 2010;9: Key Words: Alzheimer's disease amyloid plaques cerebrovascular
689701. doi: 10.1016/S1474-4422(10)70104-6. disorders dementia mild cognitive impairment